ADA also effectively reduced the growth of colorectal carcinoma, melanoma cells, prostate cancer cells, and hepatoma cells (Ocker et al., 2004; Shi et al., 2015; Li et al., 2019; Nong et al., 2022). This evidence concerns the gene ADA and colorectal carcinoma.